Loading market dashboard
Altimmune, Inc.
ALTHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Altimmune, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $172.12M | $172.12M - $172.12M | -$103.27M | -$0.63 | 7 |
| Dec 2029 | $68.17M | $68.17M - $68.17M | -$40.90M | -$0.692 | 7 |
| Dec 2028 | $94.11M | $94.11M - $94.11M | -$56.47M | -$0.889 | 8 |
| Dec 2027 | $25.73M | $25.73M - $25.73M | -$15.44M | -$0.763 | 6 |
| Dec 2026 | $5.1K | $5.1K - $5.1K | -$3.1K | -$0.687 | 6 |
| Dec 2025 | $5.6K | $5.6K - $11.1K | -$3.3K | -$0.976 | 5 |
| Dec 2024 | $1.4K | $1.4K - $1.4K | -$857.00 | -$1.349 | 4 |
| Dec 2023 | $409.0K | $409.0K - $409.0K | -$245.4K | -$1.597 | 3 |
| Dec 2022 | $34.9K | $34.9K - $34.9K | -$93.65M | -$2.004 | 1 |
| Dec 2021 | $1.18M | $1.18M - $1.18M | -$707.4K | -$2.413 | 2 |
| Dec 2020 | $7.69M | $7.69M - $7.69M | -$64.27M | -$2.563 | 2 |
| Dec 2019 | $5.98M | $5.98M - $5.98M | -$3.59M | -$1.52 | 1 |